Ultivue Inc, based in Cambridge, MA, is a leading provider of spatial phenomics solutions for precision cancer therapy development. Their innovative InSituPlex technology, combined with advanced AI-driven spatial analysis, enables scientists to generate quantitative and high-confidence insights in a fraction of the time, revolutionizing the field of biomarker research.
Ultivue offers a comprehensive range of products and services, including custom assay development, pre-optimized biomarker panels, and specialized AI tools for image analysis. Their end-to-end solution empowers researchers to gain unprecedented clarity and actionable insights into the immune landscape of tissues, accelerating the development of clinical biomarkers and driving scientific advancements in the fight against cancer.
Generated from the website